Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.20.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 28, 2020
Dec. 31, 2019
Dec. 31, 2018
Feb. 29, 2020
Working capital   $ (31,000,000)    
Net cash used in operating activities   (24,138,317) $ (2,907,857)  
Transaction costs   17,000,000    
Revenues from related party   29,029,249  
Impairment losses    
Unrecognized tax liabilities or benefits    
Convertible Debentures Payable [Member]        
Potentially dilutive securities, amount   10,000,000 8,600,000  
Convertible Promissory Notes [Member]        
Potentially dilutive securities, amount   $ 350,000 $ 350,000  
Options and Warrants [Member]        
Potentially dilutive securities, shares   18,051,357 18,916,211  
Buildings and Building Improvements [Member] | Minimum [Member]        
Estimated useful lives of property and equipment   7 years    
Buildings and Building Improvements [Member] | Maximum [Member]        
Estimated useful lives of property and equipment   39 years    
Tenant Improvements [Member]        
Estimated useful lives of property and equipment   The remaining duration of the related lease.    
Furniture and Fixtures [Member]        
Estimated useful lives of property and equipment   7 years    
Machinery and Equipment [Member] | Minimum [Member]        
Estimated useful lives of property and equipment   5 years    
Machinery and Equipment [Member] | Maximum [Member]        
Estimated useful lives of property and equipment   10 years    
Kind Therapeutics USA Inc. [Member]        
Revenues from related party   $ 9,700,000    
Harvest Foundation LLC [Member]        
Revenues from related party   239,000    
Accounts Receivable [Member]        
Debt collectible reserve   10,700,000 $ 150,000  
Accredited Investor [Member]        
Debt commitment amount   $ 120,000,000    
Loan interest rate   10.00%    
Subsequent Event [Member] | Accredited Investor [Member]        
Loan interest rate       10.00%
Subsequent Event [Member] | Exchange Agreement [Member] | Two Institutional Stockholders [Member]        
Proceeds from issuance of convertible debentures $ 4,400,000      
Addionally issuance of convertible debt 935,000      
Subsequent Event [Member] | Exchange Agreement [Member] | Two Institutional Stockholders [Member] | Extended Maturity Dates [Member]        
Promissory notes amount 194,000,000      
Subsequent Event [Member] | Exchange Agreement [Member] | Two Institutional Stockholders [Member] | Extended Another Maturity Dates [Member]        
Promissory notes amount $ 3,000,000